• Exchange: Natl India
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

Shasun Pharmaceuticals Ltd

+ Add to Watchlist

SAPH:IN

160.75 INR 0.70 0.44%

As of 04:32:59 ET on 07/14/2014.

Snapshot for Shasun Pharmaceuticals Ltd (SAPH)

Open: 160.95 Day's Range: 159.00 - 166.25 Volume: 163,758
Previous Close: 160.05 52wk Range: 48.90 - 196.70 1-Yr Rtn: +119.05%

Stock Chart for SAPH

No chart data available.
  • SAPH:IN 160.95
  • 1D
  • 1M
  • 1Y
160.05
Interactive SAPH Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for SAPH

Current P/E Ratio (ttm) 30.3464
Estimated P/E(03/2015) 12.4654
Relative P/E vs. SENSEX 1.7613
Earnings Per Share (INR) (ttm) 5.3400
Est. EPS (INR) (03/2015) 13.0000
Est. PEG Ratio -
Market Cap (M INR) 9,743.07
Shares Outstanding (M) 60.12
30 Day Average Volume 457,208
Price/Book (mrq) 3.0063
Price/Sale (ttm) 0.7487
Dividend Indicated Gross Yield 0.62%
Cash Dividend (INR) 1.0000
Dividend Ex-Date 07/30/2014
5 Year Dividend Growth 8.45%
Next Earnings Announcement 05/29/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for SAPH

  • Revenue
  • Net Income (M/INR)
  • Profit Margin (%)

Company Profile & Key Executives for SAPH

Shasun Pharmaceuticals Ltd. manufactures and develops active pharmaceutical ingredients and their intermediates. The Company produces ibuprofen derivatives, ranitidine and nizatidine and exports them to North America, Europe, Asia and Latin America.

S Abhaya KumarManaging DirectorS HariharanChief Financial Officer
S DevendraExecutive DirectorS Vimal KumarExecutive Director
More Company Profile & Key Executives for SAPH

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil